The loss of TRAIL-R1 staining in tumor cells in comparison to co-stained surrounding non-tumor tissues from the same patient is in agreement with previous reports on other tumor entities [23], [24] and with in vitro evidence showing that loss of TRAIL-receptors in pancreatic cancer cell lines contributes to a decreased sensitivity towards TRAIL-induced apoptosis [25]. The gene discussed is TNFRSF10A; the disease is neoplasm.